Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Evonik and Ethris partner on lipid nanoparticle delivery platform

    Evonik and Ethris have agreed a partnership to develop and [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    BIG D-FOOT trial results on STIMULAN to be presented at EBJIS 2025

    Biocomposites will present new clinical data from the BIG D-FOOT [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    KBI Biopharma and Infinimmune partner on antibody manufacturing for atopic dermatitis programme

    KBI Biopharma has entered a collaboration with Infinimmune to support [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Imagene AI and Sheba Medical Center form alliance to expand precision oncology with real-world data

    Imagene AI has expanded its collaboration with Sheba Medical Center [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    Causaly launches agentic AI platform for life sciences research and development

    Causaly has introduced a new artificial intelligence system that it [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    New study shows covariate adjustment improves trial precision for pain, mood and fatigue outcomes

    A study published in the Journal of Pain has shown [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Living Optics shows real-time hyperspectral imaging on NVIDIA Jetson for blood perfusion insights

    UK company Living Optics has demonstrated real-time blood perfusion imaging [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    SOM Biotech secures EMA orphan designation opinion for Huntington’s drug SOM3355

    Barcelona-based biotech advances Huntington’s programme as EMA backs orphan designation, [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Medical devices,Pharmaceuticals and therapeutics

    Lithuania sets stage for Life Sciences Baltics with multi-billion-euro investments and AI innovation

    Lithuania’s life sciences sector is preparing to showcase its rapid [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Merck halts £1bn London research centre, raising fresh concerns over UK competitiveness

    MSD, known as Merck & Co. in the US, says [...]

    May 5, 2026
Previous525354Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • LifeMine raises $263 million to advance transplant rejection therapy into Phase 2
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Research & Development
  • Kupando doses first patient in Phase 1 trial of KUP101 for advanced skin cancer
    Categories: Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Adneuris licenses cebranopadol to Maruishi in $35M Japan and South Korea deal
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top